Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic Cerebrovascular Disease JACC Scientific Expert Panel

被引:63
作者
Del Brutto, Victor J. [1 ]
Chaturvedi, Seemant [2 ]
Diener, Hans-Christoph [3 ]
Romano, Jose G. [1 ]
Sacco, Ralph L. [1 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA
[2] Univ Maryland, Dept Neurol, Baltimore, MD 21201 USA
[3] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany
基金
美国国家卫生研究院;
关键词
anticoagulants; antiplatelets; antithrombotics; ischemic stroke; secondary prevention; VERTEBRAL ARTERY-STENOSIS; MOLECULAR-WEIGHT HEPARIN; PATENT FORAMEN OVALE; RANDOMIZED-TRIAL RATIONALE; DIRECT ORAL ANTICOAGULANTS; DOSE ACETYLSALICYLIC-ACID; PLACEBO-CONTROLLED TRIAL; HIGH-RISK PATIENTS; SECONDARY PREVENTION; ANTIPLATELET THERAPY;
D O I
10.1016/j.jacc.2019.06.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stroke survivors carry a high risk of recurrence. Antithrombotic medications are paramount for secondary prevention and thus crucial to reduce the overall stroke burden. Appropriate antithrombotic agent selection should be based on the best understanding of the physiopathological mechanism that led to the initial ischemic injury. Antiplatelet therapy is preferred for lesions characterized by atherosclerosis and endothelial injury, whereas anticoagulant agents are favored for cardiogenic embolism and highly thrombophilic conditions. Large randomized controlled trials have provided new data to support recommendations for the evidence-based use of antiplatelet agents and anticoagulant agents after stroke. In this review, the authors cover recent trials that have altered clinical practice, cite systematic reviews and meta-analyses, review evidence-based recommendations based on older landmark trials, and indicate where there are still evidence-gaps and new trials being conducted. (C) 2019 by the American College of Cardiology Foundation.
引用
收藏
页码:786 / 803
页数:18
相关论文
共 134 条
[1]   Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke [J].
Amarenco, P. ;
Lavallee, P. C. ;
Tavares, L. Monteiro ;
Labreuche, J. ;
Albers, G. W. ;
Abboud, H. ;
Anticoli, S. ;
Audebert, H. ;
Bornstein, N. M. ;
Caplan, L. R. ;
Correia, M. ;
Donnan, G. A. ;
Ferro, J. M. ;
Gongora-Rivera, F. ;
Heide, W. ;
Hennerici, M. G. ;
Kelly, P. J. ;
Kral, M. ;
Lin, H. -F. ;
Molina, C. ;
Park, J. M. ;
Purroy, F. ;
Rothwell, P. M. ;
Segura, T. ;
Skoloudik, D. ;
Steg, P. G. ;
Touboul, P. -J. ;
Uchiyama, S. ;
Vicaut, E. ;
Wang, Y. ;
Wong, L. K. S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (23) :2182-2190
[2]  
Amarenco P, 1996, NEW ENGL J MED, V334, P1216
[3]   Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source [J].
Amarenco, Pierre ;
Albers, Gregory W. ;
Denison, Hans ;
Easton, J. Donald ;
Evans, Scott R. ;
Held, Peter ;
Hill, Michael D. ;
Jonasson, Jenny ;
Kasner, Scott E. ;
Ladenvall, Per ;
Minematsu, Kazuo ;
Molina, Carlos A. ;
Wang, Yongjun ;
Wong, K. S. Lawrence ;
Johnston, S. Claiborne .
STROKE, 2017, 48 (09) :2480-+
[4]   Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial [J].
Amarenco, Pierre ;
Albers, Gregory W. ;
Denison, Hans ;
Easton, J. Donald ;
Evans, Scott R. ;
Held, Peter ;
Hill, Michael D. ;
Jonasson, Jenny ;
Kasner, Scott E. ;
Ladenvall, Per ;
Minematsu, Kazuo ;
Molina, Carlos A. ;
Wang, Yongjun ;
Wong, K. S. Lawrence ;
Johnston, S. Claiborne .
LANCET NEUROLOGY, 2017, 16 (04) :301-310
[5]   Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques [J].
Amarenco, Pierre ;
Davis, Stephen ;
Jones, Elizabeth F. ;
Cohen, Ariel A. ;
Heiss, Wolf-Dieter ;
Kaste, Markku ;
Laouenan, Cedric ;
Young, Dennis ;
Macleod, Malcolm ;
Donnan, Geoffrey A. .
STROKE, 2014, 45 (05) :1248-1257
[6]   Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial [J].
Baharoglu, M. Irem ;
Cordonnier, Charlotte ;
Salman, Rustam Al-Shahi ;
de Gans, Koen ;
Koopman, Maria M. ;
Brand, Anneke ;
Majoie, Charles B. ;
Beenen, Ludo F. ;
Marquering, Henk A. ;
Vermeulen, Marinus ;
Nederkoorn, Paul J. ;
de Haan, Rob J. ;
Roos, Yvo B. .
LANCET, 2016, 387 (10038) :2605-2613
[7]   Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial [J].
Bath, Philip M. ;
Woodhouse, Lisa J. ;
Appleton, Jason P. ;
Beridze, Maia ;
Christensen, Hanne ;
Dineen, Robert A. ;
Duley, Lelia ;
England, Timothy J. ;
Flaherty, Katie ;
Havard, Diane ;
Heptinstall, Stan ;
James, Marilyn ;
Krishnan, Kailash ;
Markus, Hugh S. ;
Montgomery, Alan A. ;
Pocock, Stuart J. ;
Randall, Marc ;
Ranta, Annemarei ;
Robinson, Thompson G. ;
Scutt, Polly ;
Venables, Graham S. ;
Sprigg, Nikola .
LANCET, 2018, 391 (10123) :850-859
[8]   Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke [J].
Benavente, Oscar R. ;
Hart, Robert G. ;
McClure, Leslie A. ;
Szychowski, Jeffrey M. ;
Coffey, Christopher S. ;
Pearce, Lesly A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09) :817-825
[9]   Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review [J].
Bertoletti, Laurent ;
Benhamou, Ygal ;
Bejot, Yannick ;
Marechaux, Sylvestre ;
Cheggour, Saida ;
Aleil, Boris ;
Lellouche, Nicolas ;
Dillinger, Jean-Guillaume ;
Delluc, Aurelien .
BLOOD REVIEWS, 2018, 32 (04) :272-279
[10]   Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy [J].
Biffi, A. ;
Halpin, A. ;
Towfighi, A. ;
Gilson, A. ;
Busl, K. ;
Rost, N. ;
Smith, E. E. ;
Greenberg, M. S. ;
Rosand, J. ;
Viswanathan, A. .
NEUROLOGY, 2010, 75 (08) :693-698